Wegovy 2.4mg online Delivery UK

Wegovy 2.4mg online Delivery UK

£212.00

Wegovy 2.4mg online Delivery UK

Wegovy 2.4 mg is a prescription medication that contains semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist. It is approved for the treatment of chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol.

This description is for educational purposes only. Wegovy can only be prescribed by a licensed healthcare professional and is not available for purchase without a prescription.

What is Wegovy 2.4 mg?

  • Active ingredient: Semaglutide

  • Strength: 2.4 mg per injection (maintenance dose)

  • Form: Prefilled injection pen, administered subcutaneously once weekly

  • Drug class: GLP-1 receptor agonist

How Wegovy Works

Wegovy mimics the natural hormone GLP-1, which helps regulate appetite and food intake. It works by:

  • Slowing stomach emptying, which increases feelings of fullness

  • Reducing hunger and cravings

  • Supporting improved blood sugar control

The result is reduced calorie intake and clinically significant weight loss when combined with a reduced-calorie diet and increased physical activity.

Who May Benefit

  • Adults with obesity (BMI ≥30)

  • Adults who are overweight (BMI ≥27) with at least one related health condition (e.g., type 2 diabetes, high blood pressure, high cholesterol)

Wegovy is typically prescribed as part of a comprehensive weight-management plan that includes diet, exercise, and behavior changes.

Dosage and Administration (educational summary)

  • Treatment is usually started at a lower dose (0.25 mg once weekly) and increased gradually to minimize side effects.

  • The 2.4 mg once weekly dose is the recommended maintenance dose.

  • Administered via subcutaneous injection (under the skin of the abdomen, thigh, or upper arm).

  • Should be used on the same day each week.

Side Effects

Common side effects may include:

  • Nausea

  • Vomiting

  • Diarrhea

  • Constipation

  • Abdominal pain

Serious risks (rare):

  • Pancreatitis (inflammation of the pancreas)

  • Gallbladder disease

  • Increased risk of thyroid C-cell tumors (based on animal studies)

  • Hypoglycemia (low blood sugar), especially if used with other diabetes medicines

Safety Considerations

  • Not suitable for people with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).

  • Patients should be monitored for gastrointestinal side effects, blood sugar levels, and signs of pancreatitis.

  • Should only be prescribed by a qualified healthcare professional after proper evaluation.

Patient Counseling Points

  • Wegovy is not a quick fix — it works best alongside a reduced-calorie diet and increased physical activity.

  • Store pens in the refrigerator until ready to use.

  • If a dose is missed, it can be taken within 5 days; otherwise, skip and continue with the next scheduled dose.